Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02336971 · ClinicalTrials.gov registry record · Phase 3
Individual PE vs Couples' CBT for Combat-Related Posttraumatic Stress Disorder
A Phase 3 study of PTSD and Marital Relationship, sponsored by Toronto Metropolitan University.
- Completed
- Registry status
- Phase 3
- Development phase
- 64
- Enrollment target
- 3
- Study locations
NCT02336971: Completed Phase 3 study of PTSD and Marital Relationship, sponsored by Toronto Metropolitan University.
NCT02336971 is a Phase 3 study of PTSD and Marital Relationship that has completed, run by Toronto Metropolitan University. The registered enrollment target is 64 participants, below the 301-participant average among 154 other PTSD trials with a reported enrollment target (79% lower). The trial reports 3 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02336971, a Phase 3 study of PTSD and Marital Relationship, has completed, sponsored by Toronto Metropolitan University.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 64 participants
- Enrollment target
- 3
- Study locations
Study Summary
This study seeks to enroll 76 couples in which one of the members is a combat-veteran with PTSD. Each couple will be randomized into one of two cognitive-behavioral therapies developed specifically as a treatment for PTSD-either Prolonged Exposure (PE) \[1-4\] or Cognitive-Behavioral Couples Therapy (CBCT) \[5-7\]. Whereas, PE was developed as a one-on-one therapy that focuses on treating the individual, CBCT for PTSD incorporates the partners into therapy and seeks to directly address relationship functioning while treating the PTSD symptomatology. Both partners in each couple will complete a battery of several assessments measuring various aspects of psychological distress (e.g., depression, PTSD) and relationship functioning at five time-points throughout the study. But, only the partners assigned to the CBCT group will be involved in the actual therapy sessions. Analysis will be carried out to identify whether any significant differences exist between PE and CBCT in treating PTSD and improving relationship functioning.
Conditions Studied
Interventions
- BEHAVIORAL Prolonged Exposure
- BEHAVIORAL CBCT for PTSD
Study Locations (3)
Texas
- Fort Hood Military Base - Fort Hood
- Brooke Army Medical Center, Fort Sam Houston - Fort Sam Houston
- University of Texas Health Science Center at San Antonio - San Antonio
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 64 participants |
| Start Date | 2011-11 |
| Est. Completion | 2016-08 |
| Phase | Phase 3 |
What the finished NCT02336971 record still lists
NCT02336971 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 64 participants, a relatively small participant target, below the 301-participant average among 154 other PTSD trials with a reported enrollment target (79% lower).
The record links to 2 conditions, with PTSD appearing as the primary indexed condition, and to 2 interventions - of which Prolonged Exposure is the first listed.
NCT02336971 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT02336971 about?
NCT02336971 is a clinical study titled "Individual PE vs Couples' CBT for Combat-Related Posttraumatic Stress Disorder". This study seeks to enroll 76 couples in which one of the members is a combat-veteran with PTSD. Each couple will be randomized into one of two cognitive-behavioral therapies developed specifically as a treatment for PTSD-either Prolonged Exposure (PE) \[1-4\] or Cognitive-Behavioral Couples Therapy...
What is the current status of trial NCT02336971?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 64 participants. The study started on 2011-11. Estimated completion is 2016-08.
What conditions does trial NCT02336971 study?
This clinical trial studies the following conditions: PTSD, Marital Relationship.
What interventions are being tested in trial NCT02336971?
The interventions under investigation include: Prolonged Exposure (BEHAVIORAL), CBCT for PTSD (BEHAVIORAL).
Who is sponsoring clinical trial NCT02336971?
This trial is sponsored by Toronto Metropolitan University, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02336971 being conducted?
This trial has 3 study locations across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for PTSD
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02336971's enrollment target sits among peer trials
64 83rd of 154 higher than 72 of 154 other PTSD trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other PTSD trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Repurposing Low-Dose Clonidine for PTSD in Veterans
RECRUITING · Phase 3
-
Cooperative Studies Program #563 - Prazosin and Combat Trauma PTSD
COMPLETED · Phase 3
-
A 40-week Study to Evaluate TNX-102 SL 5.6 mg Taken Daily at Bedtime in Patients With PTSD
COMPLETED · Phase 3
-
Divalproex Sodium in the Treatment of PTSD (Post-Traumatic Stress Disorder)
COMPLETED · Phase 3
-
Testing an Integrated PTSD and Weight Management Intervention: A Hybrid Type 1 Trial
RECRUITING · NA
-
Treatments for Insomnia in Veterans With PTSD
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01853631 · 64 participants · Phase 1
Activated T-Cells Expressing 2nd or 3rd Generation CD19-Specific CAR, Advanced B-Cell NHL, ALL, and CLL (SAGAN)
- NCT03739502 · 64 participants · Phase 2
A Randomized Phase II Study of Hyperbaric Oxygen in Improving Engraftment in Umbilical Cord Blood Stem Cell Transplant
- NCT03739814 · 64 participants · Phase 2
Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia
- NCT03866408 · 64 participants · Early Phase 1
Insulin Regulation of Lipolysis and Lipolysis Proteins
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia